Further studies are being carried out to investigate the therapeutic efficacy and safety of PSMA-CAR T-cells in PCa treatment (NCT04053062, NCT04227275, NCT04249947, NCT04429451). Here, FOLH1 is linked to posterior cortical atrophy.